Acute lymphoblastic leukæmia in children;Traitement des leucémies aiguës lymphoïdes de l'enfant

Revue du Praticien

Volumn 46, Issue 1, 1996, Pages 48-54

  Schaison, Gérard ^a   Baruchel, André ^a   Leblanc, Thierry ^a  

^a SAINT LOUIS HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ACUTE LYMPHOCYTIC LEUKEMIA; ADOLESCENT; AGE; CHILD; CLASSIFICATION; HUMAN; INFANT; INFECTION; PROGNOSIS; RECURRENT DISEASE; REVIEW; ACUTE LYMPHOBLASTIC LEUKEMIA; ARTICLE; BACTERIAL INFECTION; BONE MARROW TRANSPLANTATION; IMMUNE DEFICIENCY; INTRATHECAL DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; SUBCUTANEOUS DRUG ADMINISTRATION; VIRUS INFECTION;

ADOLESCENT; AGE FACTORS; CHILD; HUMANS; INFANT; INFECTION; LEUKEMIA, LYMPHOCYTIC, ACUTE; PROGNOSIS; RECURRENCE;

ACICLOVIR; ANTIBIOTIC AGENT; ANTINEOPLASTIC AGENT; ASPARAGINASE; COTRIMOXAZOLE; CYCLOPHOSPHAMIDE; CYTARABINE; DAUNORUBICIN; DOXORUBICIN; ETOPOSIDE; FOLINIC ACID; FOSCARNET; GRANULOCYTE COLONY STIMULATING FACTOR; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; GROWTH FACTOR; IMMUNOGLOBULIN; MERCAPTOPURINE; METHOTREXATE; PREDNISONE; TIOGUANINE; VACCINE; VINCRISTINE;

EID: 0030026512     PISSN: 00352640     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Sallan SE, Gelber RD. Kimball V, Donnely M, Cohen HJ. More is better. Update of Dana-Farber Cancer Institute/Children's hospital childhood acute lymphoblastic leukemia trial, In : Buchner T, Schellong G, Hiddemann W, Ritter J (eds). Haematology and blood transfusion . Acute Leukemia II. Prognostic factors and treatment strategies. Berlin, Heidelberg: Springer-Verlag, 1990; 33 : 459-66.
2. Rivera GK, Pinkel D, Simone JV. Treatment of acute lymphoblastic leukemia. 30 years' experience at St Jude Children's research hospital. N Engl J Med 1993 ; 329 : 1289-95.
3. Crist WM, Boyett J, Pullen J, Van Eys J, Vietti T. Clinical and biological features predict poor prognosis in acute lymphoid leukemias in children and adolescents : a Pediatric Oncology Group review. Med Pediatr Oncol 1986 ; 14 : 135-9.
4. Hammond GD, Sather H, Nesbit M et al. Analysis of prognosis factors in acute lymphoblastic leukemia. Med Pediatr Oncol 1986 ; 14 : 124-34.
5. Shuster JJ. Faletta JM. Pullen DJ et al. Prognosis factors in childhood T-cell acute lymphoblastic: a Pediatric Oncology Group. Blood 1990 ; 75 : 166-73.
6. Riehm H, Gadner H, Henze G et al. Results and significance of six randomized trials in four consecutive ALL-BFM studies. In : Buchner T, Schellong G, Hiddemann W, Ritter J (eds). Haematology and Blood transfusion. Acute Leukemia H. Prognostic factors and treatment strategies. Berlin, Heidelberg: Springer-Verlag. 1990 ; 33 : 439-50.
7. Rivera GK, Raimondi SC, Hancock ML et al. Improved outcome in childhood acute lymphoblastic leukaemia with renforced early treatment and rotational combination chemotherapy. Lancet 1991 ; 337: 61-6.
8. Schaison G, Sommelet D, Leverger G et al. Treatment of acute lymphoblastic. Protocol FRALLE 83-85. Leukemia 1992 ; 6 (suppl 2): 148-53.
9. Shorin MA, Blattner S, Gelber RD et al. Treatment of childhood acute lymphoblastic leukemia : results of Dana-Farber Cancer Institute/Children's Hospital acute lymphoblastic leukemia consortium protocol 85-01. J Clin Oncol 1994 ; 12 : 740-7.
10. Tubergen DG, Gilchrist GS. O'Brien RT et al. Improved outcome with delayed intensification for children with acute lymphoblastic leukemia and intermediate presenting features; a Children's Cancer Group phase III trial, J Clin Oncol 1993 , 1 : 527-37.
11. Yamada M, Wasserman R, Lange B et al Minimal residual disease in childhood B-lineage lymphoblastic leukemia. Persistence of leukemic cells during the first 18 months of treatment. N Engl J Med 1990 ; 323 : 448-55.
12. Miller DR, Leikin SL, Albo VC, Sather H, Hammond GD. Three versus five years of maintenance therapy are equivalent in childhood acute lymphoblastic leukemia: a report from the Children's Cancer Study Group. J Clin Oncol 1989 ; 7 : 316-25.
13. Dolan G, Lilleyman JS, Richards SM. Prognostic importance of myelosuppression during maintenance treatment of lymphoblastic leukemia. Arch Dis Child 1989 ; 64 : 1231-4.
14. Pinkel D, Woo S. Prevention and treatment of meningeal leukemia in children. Blood 1994 ; 83 : 355-66.
15. Pochedly C. Prevention of meningeal leukemia. Hematol Oncol Clin North Am 1990 ; 4 . 951-69.
16. Abromowitch M, Ochs J, Pui CH et al. High-dose methotrexate improves clinical outcome in children with acute lymphoblastic leukemia : St Jude total therapy study X. Med Pediatr Oncol 1988 , 16 : 297-303.
17. Patte C, Michon J, Frappaz D et al. Therapy of Burkitt and other B cell acute lymphoblastic leukemia and lymphoma. Experience with the LMB protocol of the SFOP in children and adults. Bailliere's Clinical Hematology 1994 ; 7 : 339-48.
18. Pui CH, Rivera GK. Hancock ML et al. Clinical significance of CD10 expression in childhood acute lymphoblastic leukemia. Leukemia 1993 ; 7 : 35-40.
19. Rivera GK, George SL, Bowman WP et al Second central nervous system prophylaxis in children with acute lymphoblastic who relapse after elective cessation of therapy. J Clin Oncol 1983 ; 1 : 417-76.
20. Rivera GK, Buchanan G, Boyett JM et al. Intensive treatment of childhood acute lymphoblastic leukemia in first bone marrow relapse. N Engl J Med 1986 ; 315 : 273-7.
21. Behrendt H, Van Leeuwen E, Schuwir IH et al. The significance of an isolated central nervous system relapse, occurring at first relapse in children with acute tymphoblastic leukemia. Cancer 1989 ; 63 : 2066-72.
22. Uderzo C, Zurlo MG, Adamoli L et al. Treatment of isolated testicular relapse in childhood acute lymphoblastic leukemia; an Italian multicenter study. J Clin Oncol 1990 ; 8 : 672-7.
23. Buhrer C, Hartmann R, Fengler R et al Superior prognosis in combined compared to isolated bone marrow relapse in salvage therapy of childhood acute lymphoblastic leukemia. Med Pediatr Oncol 1993 ; 21 : 470-6.
24. Ochs JJ, Mulhern RK. Late effects of antileukemic treatment. Pediatr Clin North Am 1988 ; 35 : 815-33.
25. Clayton PE, Morris-Jones PH, Shalet SM, Price DA. Growth in children treated for acute lymphoblastic leukaemia Lancet 1988 ; 2 : 460-2.
26. Copeland DR, Fletcher JM, PfefferLevine B, Jaffe N, Ried H, Maor M. Neuropsychological sequelae of childhood cancer in long-term survivors. Pediatrics 1985 ; 75 : 745-53.
27. Doroshow JH. Doxorubicin-induced cardiotoxicity. N Engl J Med 1991 ; 324: 843-5.
28. Ron E, Modan B, Boice JD et al. Tumors of the brain and nervous system after radiotherapy in childhood. N Engl J Med 1988 ; 319 : 1033-9.